Journal of Infection and Public Health

Papers
(The H4-Index of Journal of Infection and Public Health is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Isolation and characterizations of bacteriophages to treat multi-drug resistant bacterial infections262
Getting the counterfactual right: Estimating the cost per life saved of Covid-19 lockdown policies222
Brucellosis and associated risk factors, spatial distribution and cluster analysis: Case study in Khorasan Razavi Province, Iran195
Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers135
Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase‐4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in perip121
Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months114
Editorial Board106
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation103
Epidemiological characterization and seasonality of respiratory syncytial virus in the United Arab Emirates: A five-year study at a tertiary care hospital, 2018–202298
Association between human leukocyte antigen alleles and COVID-19 disease severity89
Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan84
Antimicrobial stewardship programs in acute-care hospitals: A multicenter assessment of structure, process, and outcome indicators in Italy and Spain79
Relation between macrophage inflammatory protein-1 and intercellular adhesion molecule-1 and computed tomography findings in critically-ill saudi covid-19 patients68
Development and validation of artificial intelligence models to predict urinary tract infections and secondary bloodstream infections in adult patients67
Time of developing surgical site infections and its association with patient and procedure characteristics64
Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination59
Molecular epidemiology characteristics and detecting transmission of carbapenemase-producing enterobacterales in southwestern China59
Emergence of novel hypervirulent Acinetobacter baumannii strain and herpes simplex type 1 virus in a case of community-acquired pneumonia in China57
The trends of mortality, aetiologies and risk factors of lower respiratory infections in China from 1990 to 2019: Findings from the Global Burden of Disease Study 201956
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study55
Changes in the spatiotemporal patterns of COVID-19 in Japan from 2020 through 202353
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions51
Clinical pharmacy services in acute care setting during mass gatherings (Hajj): Insights from a task force51
Multidrug-resistant organism co-colonization in patients with discordant direct stool Xpert Carba-R and culture-based carbapenemase-producing Enterobacterales surveillance results47
In-silico design of a multi-epitope vaccine targeting conserved transmembrane proteins of Gardnerella vaginalis using immuno-informatics approach47
Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha44
CTLA-4 rs5742909 but not ADAM33 rs2280091 is a predictor factor for COVID-19 mortality43
High prevalence of anti-Strongyloides antibody in SARS-CoV-2-infected human sera in a Thai hospital: Rapid serological screening42
Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia40
Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study40
Emergence and dissemination of monkeypox, an intimidating global public health problem40
Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates40
Occupational class and risk of hepatitis B and C viral infections: A case-control study-based data from a nationwide hospital group in Japan40
COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study40
Duration of mild acute SARS-CoV-2 infections with Omicron depending on previous vaccinations and infections – Using data of the German DigiHero cohort study from post-pandemic winters 2022/2023 and 2040
Feasibility of an antimicrobial stewardship program in four district hospitals in Vietnam39
Mortality in Norway and Sweden during the COVID-19 pandemic39
Neonatal outcomes related to maternal SARS-CoV-2 infection in French Guiana: A case-control study.39
Antibiotic resistance in tick-borne bacteria: A One Health approach perspective38
Tackling antimicrobial resistance in primary care facilities across Pakistan: Current challenges and implications for the future38
Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes38
0.11409687995911